Clorox (NYSE: CLX) stock dropped heavily in Friday premarket trading, following a disappointing Q2 earnings report, missing analyst expectations, and pointing to increasing inflation issues that have negatively impacted overall growth. In a difficult period for earnings, Clorox has joined the amalgam of companies that have posted worse-than-expected earnings, with the blame focused on cost pressures in supply chains.
Clorox earnings came in at $0.66 per share for Q2 on sales of $1.69B, an 8% drop from the previous year. The general analyst consensus was adjusted earnings of $0.86 per share on sales of $1.66B. The gross margin in the quarter also declined to 33% from last year's 45%.
There wasn’t much reassurance in the company’s fiscal year outlook, with net sales expected to fall between 1% and 4%, and adjusted earning forecasted at between $4.25 and $4.50 – a cut from earlier guidance which was between $5.40 and $5.70.
Linda Rendle, CEO of Clorox, pointed out the company’s attempts at navigating market headwinds:
“In the face of a challenging cost environment, we’re executing well on the factors we control. We’re driving cost savings and pricing to mitigate inflationary headwinds, while also continuing to meet strong demand across our portfolio”
Unfortunately for the company and the wider market, cost pressures are likely to increase throughout the year, hence companies should be looking at strategies to remain competitively positioned. Rendle hopes to ‘build a stronger, more resilient company, and create long-term shareholder value’.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage . 68 % of retail investor accounts lose money when trading CFDs with this provider . You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money .